NRC Health Impairment of Long-Lived Assets Held-for-use
NRC Health (NRC) reported Impairment of Long-Lived Assets Held-for-use of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsHeldForUse · last filed 2026-03-05
- NRC Health impairment of long-lived assets held-for-use for the quarter ending 2014-06-30 was $0.00.
- NRC Health impairment of long-lived assets held-for-use for the quarter ending 2014-03-31 was $0.00.
- NRC Health impairment of long-lived assets held-for-use for fiscal 2025 was $0.00.
- NRC Health impairment of long-lived assets held-for-use for fiscal 2024 was $0.00.
- NRC Health impairment of long-lived assets held-for-use for fiscal 2023 was $0.00.
- NRC Health impairment of long-lived assets held-for-use for fiscal 2022 was $0.00.
| Period end | Impairment of Long-Lived Assets Held-for-use 3 month | Impairment of Long-Lived Assets Held-for-use 6 month | Impairment of Long-Lived Assets Held-for-use 12 month |
|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-05 | ||
| 2024-12-31 | $0.00 10-K · filed 2026-03-05 | ||
| 2023-12-31 | $0.00 10-K · filed 2026-03-05 | ||
| 2022-12-31 | $0.00 10-K · filed 2025-03-17 | ||
| 2021-12-31 | $0.00 10-K · filed 2024-02-27 | ||
| 2020-12-31 | $0.00 10-K · filed 2023-03-03 | ||
| 2019-12-31 | $0.00 10-K · filed 2022-03-04 | ||
| 2018-12-31 | $0.00 10-K · filed 2021-03-05 | ||
| 2018-06-30 | $2.00K 10-Q · filed 2018-08-09 | ||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06 | $0.00 10-Q · filed 2014-08-06 | |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-08 | ||
| 2013-12-31 | $0.00 10-Q · filed 2014-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |